<DOC>
	<DOC>NCT00145262</DOC>
	<brief_summary>Clinical studies have established that implantation of bone marrow mononuclear cells (BM-MNCs) or peripheral blood mononuclear cells (PB-MNCs) into ischaemic limbs increases collateral vessel formation. We, the investigators at Nagoya University, further investigated the efficacy and safety of autologous implantation of BM-MNCs or PB-MNCs in patients with severe ischaemic limbs who have no other alternative therapeutic options. We also examined a potential limiting factor which reduced the efficacy of therapeutic angiogenesis using cell transplantation (TACT).</brief_summary>
	<brief_title>TACT-NAGOYA: Therapeutic Angiogenesis Using Cell Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Arteriosclerosis</mesh_term>
	<mesh_term>Thromboangiitis Obliterans</mesh_term>
	<mesh_term>Arteriosclerosis Obliterans</mesh_term>
	<criteria>Subjects who have chronic limb ischemia, including rest pain, nonhealing ischemic ulcers, or both, and who are not candidates for nonsurgical or surgical revascularisation. Poorly controlled diabetes mellitus (hemoglobin A1c [HbA1c] &gt; 6.5% and proliferative retinopathy) Evidence of malignant disorder during the past 5 years Subjects who cannot survive more than 1 year with other complications Malignant rheumatic arthritis</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2003</verification_date>
	<keyword>critical limb ischemia</keyword>
	<keyword>bone marrow mononuclear cells</keyword>
	<keyword>angiogenesis</keyword>
	<keyword>vasculogenesis</keyword>
	<keyword>Arteriosclerosis Obliterans (ASO)</keyword>
	<keyword>Ischemic ulcers</keyword>
</DOC>